Arcus Biosciences Inc Cash Flow Quality Index

Latest as of December 2021: -0.22x

Arcus Biosciences Inc cash flow quality index. Arcus Biosciences Inc (RCUS) has a Cash Flow Quality Index of -0.22x as of December 2021. Operating cash flow of $-62.10 Million is below net income of $279.37 Million, suggesting accrual-heavy earnings not yet converted to cash. See Arcus Biosciences Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.22x
Operating CF / Net Income

Operating Cash Flow

$-62.10 Million
USD

Net Income

$279.37 Million
USD

Data as of

Dec 2021
Most recent filing

Cash Flow Quality Index of Arcus Biosciences Inc (2021–2021)

Cash flow quality index of Arcus Biosciences Inc from 2021 to 2021. Historical Cash Flow Quality Index for Arcus Biosciences Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore RCUS operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Arcus Biosciences Inc Cash Flow Quality Index by Year (2021–2021)

Arcus Biosciences Inc cash flow quality index by year from 2021 to 2021. Year-by-year earnings quality comparison for Arcus Biosciences Inc. For the full cash flow conversion analysis, see Arcus Biosciences Inc cash conversion from operations.

Year Quality Index Operating CF (USD) Net Income YoY Change
2021 -4.85x $-256.17 Million $52.83 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.